At a glance
Learn how impedance spectroscopy detects early-stage blood loss and how Sciospec’s ISX3 analyzer support trauma monitoring applications
Full reference article
Detecting Early Hypovolemia with EIS in Human LBNP Studies
The recent publication, “Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure model” explores how advanced monitoring methods can detect early signs of internal blood volume loss. Using a lower body negative pressure (LBNP) model to simulate hypovolemia, researchers assessed whether impedance-based technologies : Electrical Impedance Spectroscopy (EIS) and Electrical Impedance Tomography (EIT) could identify physiological changes before traditional vital signs like heart rate or blood pressure.
Sciospec’s ISX-3 system was a core component of this study providing high-resolution, non-invasive measurements of thoracic and abdominal impedance. These changes were evident well before positioning EIS as a powerful tool in non-invasive hemodynamic monitoring.
*Murphy, E.K., Bertsch, S.R., Klein, S.B., Rashedi, N., Sun, Y., Joyner, M.J., Curry, T.B., Johnson, C.P., Regimbal, R.J., Wiggins, C.C., Senefeld, J.W., Shepherd, J.R.A., Elliott, J.T., Halter, R.J., Vaze, V.S., & Paradis, N.A. Non-invasive biomarkers for detecting progression toward hypovolemic cardiovascular instability in a lower body negative pressure model. Scientific Reports (2024). https://www.nature.com/articles/s41598-024-59139-8
Why This Research Matters
Early detection of hypovolemia remains a clinical challenge. Conventional indicators such as low blood pressure often lag behind actual blood loss delaying intervention. This study showed that thoracic impedance metrics measured with EIS and EIT were more sensitive than traditional vital signs for identifying early-stage hypovolemia.
Data collected using the Sciospec ISX-3 impedance analyzer revealed signal shifts that allowed researchers to detect blood volume changes sooner and with greater precision. The ISX-3’s high-frequency resolution and stable signal output proved critical in capturing early hemodynamic shifts making it a key enabler in this human subject study.
🔍Explore how impedance-based diagnostics can reveal subtle physiological changes. View our research-ready systems.
Photo of a subject with sensors attached prior to starting the LBNP experiment.
Absolute metric values displayed via quartile box-and-whisker plots. Black dots indicate any subject outside of the quartiles and the median value is shown as a black line segment.
Sciospec’s Technological Contribution in Early-Stage Hypovolemia Monitoring
The research team used the Sciospec ISX-3 impedance analyzer to measure changes in impedance across the chest, abdomen, and arms during staged blood volume reductions. The ISX-3’s high-resolution, multifrequency capabilities allowed for detailed tissue analysis over time.This enabled:
- Real-time impedance tracking across anatomical zones
Clear differentiation between baseline and hypovolemic states
Input for machine learning models to support predictive diagnostics
👉 Want to Learn how our platforms enable real-time physiological research? Contact Our team to learn how our solutions can assist your research.
How Sciospec Enables Physiological Signal Detection
Sciospec ISX-3’s system helps detect physiological changes before they manifest as clinical symptoms. In this study, impedance shifts gave earlier warnings than heart rate or blood pressure readings.
Key features of the Sciospec EIS platform:
- Multi-frequency analysis: Enables tissue-specific detection across broad bandwidths
- Stable signal performance: Reliable under dynamic, real-time conditions
- Flexible sensor integration:Compatible with various electrode layouts and body regions
👉 Planning a physiological study using EIS? Explore the ISX-3 analyzer for life science applications.
Scaling EIS for Broader Applications
While this study used a single-subject model, many physiological research settings require higher throughput or multi-site monitoring. The ISX-3 platform supports up to 64 channels with modular multiplexers, allowing:
- Simultaneous monitoring of multiple anatomical sites
- Efficient data acquisition across subject groups
- Configurable sensor arrays for diverse research protocols
👉 Need a scalable impedance platform? See how our modular EIS systems scale from pilot to clinical trial
For clinical and translational research, the Medical Research ISX-3 combines high-performance measurement with safety-focused design. It integrates smoothly into:
- Non-invasive wearable systems
- Multi-modality setups (e.g., imaging + biosensors)
- Trials requiring customized or compliant setups
🏥 Evaluate how the Medical Research ISX-3 can accelerate your clinical development pipeline. See technical details and clinical use features
Want to dive deeper? Talk to our experts!
Our experts are ready to help you understanding how this technology works and how you can apply and integrate it into your work. Get in touch today to get a personalized consultation to enhance your work with our advanced solutions
Advancing Early Hypovolemia Detection with the Sciospec ISX-3
This study reinforces the value of impedance spectroscopy as a non-invasive tool for early hypovolemia detection. Sciospec’s ISX-3 system enabled the precise, flexible signal acquisition needed to capture physiological changes ahead of traditional vital signs.
👉 Looking to integrate high-resolution impedance into your study? Request expert guidance on building your EIS-based study
💡Curious for more? Check out our latest developments and products.
🧪Want to try it yourself? Contact us for more information
🚀Looking for a tailored solution? Our experts can help!
📢 Follow us on LinkedIn for more updates.
#Innovation #Sciospec #EarlyHypovolemia #physiologicalresearch
Explore Related Research and Insights
explore by relevant keywords
Get in touch with us
Frequently asked questions
What is lower body negative pressure (LBNP) and why is it used in blood-loss research ?
Answer:
Lower body negative pressure (LBNP) is a laboratory technique that applies mild suction to the lower half of the body, causing blood to pool in the legs. This safely mimics early-stage hypovolemia without removing actual blood and allows researchers to study cardiovascular responses under controlled conditions. LBNP enables the evaluation of non-invasive hemodynamic monitoring methods by replicating internal volume shifts before typical vital signs like blood pressure or heart rate begin to change. In several studies using Sciospec’s ISX-3 platform, impedance measurements reflected these shifts with high sensitivity.
👉 Interested in how impedance-based monitoring responds to simulated blood loss? Learn more about our ISX-3
How does electrical impedance spectroscopy (EIS) detect internal bleeding before vital signs change ?
Electrical impedance spectroscopy measures how tissues respond to small, varying electrical currents. As blood volume changes in areas like the chest or arms during early-stage hemorrhage, the electrical properties (resistance and phase) shift accordingly .In recent studies, including LBNP trials, EIS has reliably detected impedance shifts before traditional clinical indicators like heart rate or blood pressure responded especially when monitoring impedance relative to baseline. Devices such as the Sciospec ISX‑3 enable these precise, time-based measurements.
Which body regions are most effective for impedance-based blood loss detection ?
Research has shown that impedance changes in different areas respond differently during hypovolemia. For example, one study noted that impedance in the chest (thorax) is highly sensitive to early fluid shifts, while another found opposing changes in arm versus leg impedance as blood pooled in the lower body. By comparing signals from multiple anatomic locations, researchers can improve detection sensitivity. Systems like Sciospec’s ISX-3 platform support these multi-site measurements enabling comparative analysis during research.
How accurate is impedance spectroscopy at estimating blood loss ?
Studies using LBNP have found strong statistical correlations between impedance changes and simulated blood volume loss. For instance, limb impedance values closely matched estimated blood loss with high correlation coefficients. These findings suggest multi-region impedance spectroscopy may offer semi-quantitative insight into blood volume changes. The Sciospec EIS system : ISX-3 captures these shifts with precision across multiple frequencies, supporting research into estimating fluid loss without invasive methods.
What are the current limitations of impedance-based hypovolemia detection ?
While impedance techniques offer early detection benefits, they also come with challenges. Individual anatomy, electrode placement, posture, and fluid status can influence readings Additionally, impedance methods like EIS and EIT often work best when interpreted relative to a baseline measurement and may need to be combined with other data for highest accuracy.
How early can impedance spectroscopy detect blood loss ?
Impedance spectroscopy can detect blood volume changes at very early stages—sometimes within minutes of fluid shift onset—well before traditional signs like blood pressure drop. In controlled LBNP studies, impedance changes were observed even at low suction levels (e.g., 15 mmHg), corresponding to blood loss under 500 mL.
Systems like the Sciospec ISX-3 enable high-resolution tracking of these subtle shifts, making them valuable in early-detection research
Is impedance monitoring non-invasive ?
Yes, impedance monitoring is completely non-invasive. It uses surface electrodes to apply small alternating currents and measures how body tissues respond—without needles, blood draws, or imaging. This makes it ideal for continuous, real-time physiological monitoring in both lab and clinical settings.
The ISX-3 platform supports non-invasive setups across thoracic, abdominal, or limb regions, giving researchers flexibility without compromising signal quality.
How does Sciospec equipment support clinical sensor design ?
Sciospec’s equipment including the ISX-3 is engineered for integration with a wide range of custom sensors, from wearable patches to biochip arrays. With scalable architecture, configurable input channels, and real-time data streaming, it allows researchers and developers to prototype and validate sensor systems for clinical or field use.
This flexibility makes it a reliable foundation for translational studies and early-stage medical device development.
